Note 31  Related party information  continued  Associates and joint ventures  Balances arising from lending and borrowing activities between the Consolidated Entity and its associates and joint ventures are  typically repayable on demand, but may be extended on a term basis and where appropriate may be either subordinated or  collateralised.  The following balances with associates and joint ventures were outstanding as at financial year end (these exclude amounts which in  substance form part of the Consolidated Entity's net investment in associates, disclosed in note 15 – Interests in associates and  joint ventures accounted for using the equity method):  Transactions between the Consolidated Entity and its associates and joint ventures principally arise from the provision of corporate  advisory services, the granting of loans, derivative transactions and the provision of management services. All transactions  undertaken with associates and joint ventures are eliminated where they are unrealised, to the extent of ownership interests held by  the Consolidated Entity, in the consolidated income statement.  During the financial year, the following income/(expense) resulted from transactions with associates and joint ventures:  (1) Fee and commission income includes all fees charged to associates.  (2) Gains on sale of securities are shown after elimination of unrealised profits or losses calculated by reference to the Consolidated Entity's  ownership interest in the associate. (3) Dividends and distributions are shown as gross amounts. Under the equity method, these amounts are not taken up as income but are  recorded as a reduction of the carrying amount of the investment.  Consolidated 2014  $m  Consolidated 2013  $m  Company  2014  $m  Company  2013  $m  Amounts receivable  488  648  –  –  Amounts payable  (235)  (120)  –  –  Consolidated 2014  $m  Consolidated 2013  $m  Company  2014  $m  Company  2013  $m  Interest income received/receivable  2  –  –  –  Fee and commission income (1) 599  531  –  –  Other income  2  1  –  –  Gains on sale of securities (note 2) (2) 61  208  –  –  Dividends and distributions (3) 101  103  –  –  Brokerage, commission and trading-related expenses  (5)  (5)  –  –  149 